US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 30, 2022 (4 years ago)

HYDROmorphone HCl Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

HYDROmorphone HCl Injection, USP, 6 mg/30 mL (0.2 mg/mL) syringes, 5 x 30 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-529-30

Recalling firm
Nephron Sterile Compounding Center LLC
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1256-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hydromorphone recalls

See all
Class III · Low risk Ongoing

Hydromorphone HCL PF

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

STAQ Pharma, Inc. NDC 73177-0104-05 D-0023-2026
Class III · Low risk Terminated

HYDROmorphone Hydrochloride 50mg/50mL

Reason Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..

OurPharma LLC NDC 73013-1040-01 D-0385-2025